William Chou - 15 Mar 2024 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
15 Mar 2024
Net transactions value
$0
Form type
4
Filing time
19 Mar 2024, 16:09:07 UTC
Previous filing
05 Apr 2023
Next filing
29 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +575,000 $0.000000 575,000 15 Mar 2024 Common Stock 575,000 $1.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.